2023
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept
Aminu M, Daver N, Godoy M, Shroff G, Wu C, Torre-Sada L, Goizueta A, Shannon V, Faiz S, Altan M, Garcia-Manero G, Kantarjian H, Ravandi-Kashani F, Kadia T, Konopleva M, DiNardo C, Pierce S, Naing A, Kim S, Kontoyiannis D, Khawaja F, Chung C, Wu J, Sheshadri A. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Frontiers In Immunology 2023, 14: 1249511. PMID: 37841255, PMCID: PMC10570510, DOI: 10.3389/fimmu.2023.1249511.Peer-Reviewed Original ResearchConceptsImmune checkpoint inhibitorsGround-glass opacitiesBlood biomarkersImmune checkpoint inhibitor pneumonitisCheckpoint inhibitor pneumonitisAcute myeloid leukemiaPost-test probabilityCheckpoint inhibitorsMyeloid leukemiaCT patternsLung inflammationPneumonitisInfected lungsRelevant blood biomarkersDiagnostic valueLung parenchymaPneumoniaCT imagesBloodBiomarkersPatientsHabitat imagesBlood modelDetection of pneumoniaLeukemia
2022
Unilateral Pneumonitis and Hydropneumothorax Following Pembrolizumab
Sanchez A, Kahn P, Minerowicz C, Kluger H. Unilateral Pneumonitis and Hydropneumothorax Following Pembrolizumab. Journal Of Brown Hospital Medicine 2022, 2: 39747. PMID: 40046551, PMCID: PMC11878863, DOI: 10.56305/001c.39747.Peer-Reviewed Case Reports and Technical NotesCheckpoint inhibitor pneumonitisTransbronchial biopsy resultsBronchoalveolar lavage fluidProgressive dyspneaDry coughPembrolizumab monotherapyLavage fluidRadiographic findingsBiopsy resultsMetastatic melanomaPleural fluidPneumonitisHydropneumothoraxPembrolizumabDyspneaMonotherapyCoughPneumoniaMelanomaSymptomsInfectionWeeks
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply